Another example is the CD4+ T cell immunity against human papilloma virus (HPV-16): while strong E2- and E6-specific, Th1/Th2 mixed CD4+ T cell responses are frequently detected in healthy women, they are absent or strongly impaired in patients with cervical cancer [75]. The gene discussed is CD4; the disease is cervical carcinoma.